TSP-1 and PPAR-γ expression in gliomas may also serve as indicators for tumor malignancy and prognosis, whereas TGF-β promotes angiogenesis during glioma progression and its expression is correlated with the degree of malignancy. This evidence concerns the gene TGFB1 and central nervous system cancer.